Premier Path Wealth Partners LLC Invests $549,000 in The Clorox Company $CLX

Premier Path Wealth Partners LLC purchased a new stake in shares of The Clorox Company (NYSE:CLX) during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 5,302 shares of the company’s stock, valued at approximately $549,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Vermillion & White Wealth Management Group LLC purchased a new position in Clorox during the third quarter valued at $25,000. Caitlin John LLC grew its position in shares of Clorox by 1,807.1% in the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock worth $27,000 after buying an additional 253 shares during the period. Darwin Wealth Management LLC purchased a new stake in shares of Clorox in the 2nd quarter worth about $29,000. Vision Financial Markets LLC increased its stake in shares of Clorox by 166.7% in the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after acquiring an additional 200 shares in the last quarter. Finally, SHP Wealth Management purchased a new position in Clorox during the 4th quarter valued at about $35,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on CLX. The Goldman Sachs Group restated a “sell” rating and issued a $83.00 price objective on shares of Clorox in a report on Friday, May 1st. Citigroup lowered their target price on shares of Clorox from $110.00 to $97.00 and set a “neutral” rating for the company in a report on Friday, May 1st. Jefferies Financial Group dropped their price target on Clorox from $139.00 to $125.00 and set a “buy” rating on the stock in a research report on Monday, May 4th. Barclays cut their price target on Clorox from $102.00 to $85.00 and set an “underweight” rating on the stock in a research note on Friday, May 1st. Finally, Morgan Stanley lowered their price objective on Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a research note on Friday, May 1st. One investment analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Clorox presently has an average rating of “Reduce” and a consensus target price of $103.40.

Insider Transactions at Clorox

In related news, Director Pierre R. Breber purchased 5,000 shares of the company’s stock in a transaction dated Tuesday, May 5th. The shares were purchased at an average price of $85.82 per share, with a total value of $429,100.00. Following the acquisition, the director directly owned 18,000 shares in the company, valued at $1,544,760. The trade was a 38.46% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.63% of the company’s stock.

Clorox Stock Performance

Shares of CLX opened at $97.15 on Friday. The business’s fifty day simple moving average is $94.21 and its two-hundred day simple moving average is $104.28. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03. The Clorox Company has a 12 month low of $84.70 and a 12 month high of $132.03. The company has a market cap of $11.75 billion, a price-to-earnings ratio of 15.77, a P/E/G ratio of 0.45 and a beta of 0.54.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, topping the consensus estimate of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The firm had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same quarter in the previous year, the business earned $1.45 earnings per share. The company’s revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Research analysts anticipate that The Clorox Company will post 5.61 earnings per share for the current fiscal year.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.